Learn more at LeadIQ.com

Insights

Market Focus Myovant Sciences is primarily focused on women’s health and prostate cancer, presenting opportunities to offer specialized healthcare solutions, pharmaceutical partnerships, and targeted medical devices tailored to these critical patient segments.

Recent Funding & Growth With a notable IPO raising $218 million and recent investments of around $200 million, the company is in a growth phase, potentially seeking strategic partnerships, innovative technology integrations, and expansion of research collaborations.

Regulatory and Legal Environment Ongoing investigations into securities law violations indicate a need for compliance and legal consultancy services, as well as risk management solutions for navigating regulatory challenges in biotech and pharmaceutical operations.

Operational Changes Recent layoffs and a reduction in headcount suggest a focus on operational efficiency and restructuring, which could open opportunities for HR technology providers, restructuring consultants, and services aimed at optimizing organizational workflows.

Strategic Partnerships Collaborations like the partnership with Femtech World signal an openness to engage with innovative health and tech platforms, providing avenues for joint ventures, digital health solutions, and patient engagement technologies to enhance product reach.

Similar companies to Myovant Sciences

Myovant Sciences Tech Stack

Myovant Sciences uses 8 technology products and services including jsDelivr, Workiva, Google Cloud, and more. Explore Myovant Sciences's tech stack below.

jsDelivr
Content Delivery Network
Workiva
Governance, Risk And Compliance
Google Cloud
Infrastructure As A Service
React
Javascript Frameworks
Video.js
Javascript Libraries
Hootsuite
Marketing
VMware
Virtualisation Software
Acquia Cloud Site Factory
Web Hosting

Media & News

Myovant Sciences's Email Address Formats

Myovant Sciences uses at least 1 format(s):

Myovant Sciences Email Formats	Example	Percentage
First.Last@myovant.com	John.Doe@myovant.com	97%
Last@myovant.com	Doe@myovant.com	2%
First.L@myovant.com	John.D@myovant.com	1%

Frequently Asked Questions

Where is Myovant Sciences's headquarters located?

Myovant Sciences's main headquarters is located at 2000 Sierra Point Parkway, 9th Floor Brisbane, CA 94005, US. The company has employees across 4 continents, including North AmericaAsiaEurope.

What is Myovant Sciences's phone number?

You can contact Myovant Sciences's main corporate office by phone at

+1-650-238-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Myovant Sciences's stock symbol?

Myovant Sciences is a publicly traded company; the company's stock symbol is MYOV.

What is Myovant Sciences's official website and social media links?

Myovant Sciences's official website is myovant.com and has social profiles on LinkedIn Crunchbase.

What is Myovant Sciences's SIC code NAICS code?

Myovant Sciences's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Myovant Sciences have currently?

As of October 2025, Myovant Sciences has approximately 85 employees across 4 continents, including North AmericaAsiaEurope. Key team members include Vice President , Medical Affairs: S. R.Owner/ Instuctor: P. A.President: W. C.. Explore Myovant Sciences's employee directory with LeadIQ.

What industry does Myovant Sciences belong to?

Myovant Sciences operates in the Biotechnology Research industry.

What technology does Myovant Sciences use?

Myovant Sciences's tech stack includes jsDelivrWorkivaGoogle CloudReactVideo.jsHootsuiteVMwareAcquia Cloud Site Factory.

What is Myovant Sciences's email format?

Myovant Sciences's email format typically follows the pattern of First.Last@myovant.com. Find more Myovant Sciences email formats with LeadIQ.

How much funding has Myovant Sciences raised to date?

As of October 2025, Myovant Sciences has raised $200M in funding. The last funding round occurred on Aug 05, 2020 for $200M.

When was Myovant Sciences founded?

Myovant Sciences was founded in 2016.

Myovant Sciences

Myovant Sciences

Biotechnology ResearchUnited States51-200 Employees

This page is no longer active or monitored. Myovant Sciences Inc. is now Sumitomo Pharma America (SMPA), while Myovant Sciences GmbH is Sumitomo Pharma Switzerland GmbH (SMPS). We are a science-based, technology-driven biopharmaceutical company focused on delivering therapeutic and scientific breakthroughs in areas of critical patient need. See pinned post for our new page and follow us!        ⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀
====
         
We aspire to be the leading healthcare company focused on redefining care for women’s health and prostate cancer. Our experienced team brings significant breadth and depth of expertise in drug development, combined with a commitment to develop new treatments for women suffering from uterine fibroids, endometriosis, and infertility, and men suffering from prostate cancer. We strive to improve the lives of millions of people, while building an innovative, dynamic, and collaborative company where employees thrive. 

Read our LinkedIn Community Guidelines at http://myovant.com/community-guidelines

Company Overview

Headquarters: 2000 Sierra Point Parkway, 9th Floor Brisbane, CA 94005, US
Phone number: +1-650-238-****
Website: myovant.com
SIC Code: 8733 - Noncommercial Research Organizations
Stock Symbol: MYOV
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded: 2016
Employees: 51-200

Media & News

Funding & Financials

$200M
Myovant Sciences has raised a total of $200M of funding over 5 rounds. Their latest funding round was raised on Aug 05, 2020 in the amount of $200M.
$25M$50M
Myovant Sciences's revenue is estimated to be in the range of $25M$50M

Funding & Financials

$200M
Myovant Sciences has raised a total of $200M of funding over 5 rounds. Their latest funding round was raised on Aug 05, 2020 in the amount of $200M.
$25M$50M
Myovant Sciences's revenue is estimated to be in the range of $25M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.